Product Image

Contributor Information

  • Name Ayham Alnabulsi
  • Institute Vertebrate Antibodies Limited

Tool Details

  • Tool name: Anti-Cytochrome P450 26C1 [T6P1C7*E7]
  • Clone: T6P1C7*E7
  • Tool type: Antibodies
  • Tool sub-type: Primary antibody
  • Class: Monoclonal
  • Conjugate: Unconjugated
  • Reactivity: Human ; Mouse ; Rat
  • Host: Mouse
  • Cancer type: Digestive / Gastrointestinal cancer
  • Application: IHC ; WB
  • Strain: Balb/c
  • Description: CYP26C1 is not expressed in in colorectal cancer but detected in the liver.
  • Immunogen: Ovalbumin-conjugated synthetic peptide RWELATPAFP (C-terminal sequence)
  • Isotype: IgG1 kappa
  • Research area: Cancer; Tissue-specific biology; Cell signaling and signal transduction; Metabolism
  • Myeloma used: P3X63Ag8.653

  • For Research Use Only

Target Details

  • Target: Cytochrome P450, family 26, subfamily C, polypeptide 1 (CYP26C1)
  • Target background: CYP26C1 is not expressed in in colorectal cancer but detected in the liver.

Application Details

  • Application: IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15°C to -25°C
  • Shipping conditions: Shipping at 4°C

Documentation

Related Tools

Product Image

Anti-RSV Subgroup B Phosphoprotein [4-14]

#151851
Product Image

Anti-HuD [15A9] (ChIP Grade)

#153502
Product Image

Anti-CD53 [OX80]

#156537

References

  • •  Brown et al. 2014. PLoS One. 9(3):e90776. PMID: 24608339.
  • •  The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer.